Investing in 0—>1(Idea—>IP)
Viva Ventures Biotech Fund: Accessing $2 Trillion Global Pharmaceutical Market
VIVA VENTURE BIOTECH FUND
Viva Ventures Biotech Fund leverages 24 scientific GP partners to invest in 0->1 (idea to pre-clinical, first-in-class) drug discovery startups. The fund uses a peer-to-peer review method and selects 12-15 startups from 600+ deals reviewed per year. Viva Ventures targets blockbuster or billion dollar-sales new drug/ distributive innovative biotech startups with a success rate of over 60%, potential 3 X annual return, over 2-3 years investment period.
For more details about Viva Ventures Biotech Fund, please visit: www.VivaVenturesBiotech.com,
or send an inquiry to Xiliu@vivaventuresbiotech.com.
Quantitative Strategy Fund
Stepstone co-investment fund
OTHER DIRECT INVESTMENT
Interest-aligned, 10-year partnering with global veteran drug hunters
18 years experience in providing financial services to near 1000 investors
20 years experience in investment risk control
Global Capital Allocation
20 years experience in first-tier investment banks in London, Hongkong and Beijing
We look forward to new talents joining us or business collaboration. Please feel free to send your inquiry to firstname.lastname@example.org.